Episode 101 explores how quantum machine learning is being used to screen molecular candidates in early-stage drug discovery. Lucas and Luna break down a concrete example: how researchers at a pharmaceutical company recently used a quantum-classical hybrid model to reduce the time needed to identify promising drug-like molecules from months to weeks. They discuss the specific algorithm — a variational quantum eigensolver combined with a classical neural net — and why it outperforms classical-only approaches on certain molecular property prediction tasks. The hosts also address current limitations: qubit counts, noise, and the difficulty of encoding large molecular structures. A practical, numbers-driven look at where quantum computing is already delivering real results in pharma, without the hype.

#QuantumMachineLearning #DrugDiscovery #Pharmaceuticals #QuantumComputing #MolecularSimulation #VariationalQuantumEigensolver #VQE #HybridQuantumClassical #DrugDesign #ComputationalChemistry #Technology #AI #MachineLearning #Fexingo #BusinessPodcast #FexingoBusiness #Healthcare #Innovation

Keep every episode free: buymeacoffee.com/fexingo